BRUKER CORPORATION Financing Cash Flow
BRUKER CORPORATION (BRKR) reported Financing Cash Flow of -$55.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- BRUKER CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $149.20M, a 56.23% increase year-over-year.
- BRUKER CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$204.90M.
- BRUKER CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$167.60M.
- BRUKER CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $258.40M.
- BRUKER CORPORATION net cash provided by (used in) financing activities for fiscal 2025 was $135.10M, a 89.01% decline from fiscal 2024.
- BRUKER CORPORATION net cash provided by (used in) financing activities for fiscal 2024 was $1.23B.
- BRUKER CORPORATION net cash provided by (used in) financing activities for fiscal 2023 was -$193.40M.
- BRUKER CORPORATION net cash provided by (used in) financing activities for fiscal 2022 was -$415.30M, a 230.31% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $149.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$55.70M 10-Q · filed 2026-08-05 | -$223.30M derived: sum of 3 quarters · filed 2026-08-05 | $35.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$204.90M 10-Q · filed 2026-05-07 | -$372.50M derived: sum of 2 quarters · filed 2026-05-07 | -$114.10M derived: sum of 3 quarters · filed 2026-05-07 | -$18.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$167.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $90.80M derived: sum of 2 quarters · filed 2026-02-27 | $186.30M derived: sum of 3 quarters · filed 2026-08-05 | $135.10M 10-K · filed 2026-02-27 |
| 2025-09-30 | $258.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $353.90M derived: sum of 2 quarters · filed 2026-08-05 | $302.70M 10-Q · filed 2025-11-05 | $227.70M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $95.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $44.30M 10-Q · filed 2026-08-05 | -$30.70M derived: sum of 3 quarters · filed 2026-08-05 | -$33.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$51.20M 10-Q · filed 2026-05-07 | -$126.20M derived: sum of 2 quarters · filed 2026-05-07 | -$128.90M derived: sum of 3 quarters · filed 2026-05-07 | $1.03B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$77.70M derived: sum of 2 quarters · filed 2026-02-27 | $1.08B derived: sum of 3 quarters · filed 2026-02-27 | $1.23B 10-K · filed 2026-02-27 |
| 2024-09-30 | -$2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.15B derived: sum of 2 quarters · filed 2025-11-05 | $1.30B 10-Q · filed 2025-11-05 | $1.24B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.16B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.31B 10-Q · filed 2025-08-06 | $1.25B derived: sum of 3 quarters · filed 2026-02-27 | $1.16B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $151.70M 10-Q · filed 2025-05-07 | $91.80M derived: sum of 2 quarters · filed 2026-02-27 | -$700.00K derived: sum of 3 quarters · filed 2026-02-27 | -$11.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$59.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$152.40M derived: sum of 2 quarters · filed 2026-02-27 | -$162.70M derived: sum of 3 quarters · filed 2026-02-27 | -$193.40M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$92.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$102.80M derived: sum of 2 quarters · filed 2024-11-07 | -$133.50M 10-Q · filed 2024-11-07 | -$169.60M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$10.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$41.00M 10-Q · filed 2024-08-09 | -$77.10M derived: sum of 3 quarters · filed 2025-03-03 | -$159.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$30.70M 10-Q · filed 2024-05-10 | -$66.80M derived: sum of 2 quarters · filed 2025-03-03 | -$148.80M derived: sum of 3 quarters · filed 2025-03-03 | -$228.60M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$36.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$118.10M derived: sum of 2 quarters · filed 2025-03-03 | -$197.90M derived: sum of 3 quarters · filed 2025-03-03 | -$415.30M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$161.80M derived: sum of 2 quarters · filed 2023-11-09 | -$379.20M 10-Q · filed 2023-11-09 | $25.10M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$79.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$297.20M 10-Q · filed 2023-08-09 | $107.10M derived: sum of 3 quarters · filed 2024-02-29 | $104.50M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$217.40M 10-Q · filed 2023-05-10 | $186.90M derived: sum of 2 quarters · filed 2024-02-29 | $184.30M derived: sum of 3 quarters · filed 2024-02-29 | $139.40M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $404.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $401.70M derived: sum of 2 quarters · filed 2024-02-29 | $356.80M derived: sum of 3 quarters · filed 2024-02-29 | $318.70M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$47.50M derived: sum of 2 quarters · filed 2022-11-04 | -$85.60M 10-Q · filed 2022-11-04 | -$159.90M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$44.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$83.00M 10-Q · filed 2022-08-05 | -$157.30M derived: sum of 3 quarters · filed 2023-03-01 | -$382.80M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$38.10M 10-Q · filed 2022-05-06 | -$112.40M derived: sum of 2 quarters · filed 2023-03-01 | -$337.90M derived: sum of 3 quarters · filed 2023-03-01 | -$391.00M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$74.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$299.80M derived: sum of 2 quarters · filed 2023-03-01 | -$352.90M derived: sum of 3 quarters · filed 2023-03-01 | -$161.60M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$225.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$278.60M derived: sum of 2 quarters · filed 2021-11-05 | -$87.30M 10-Q · filed 2021-11-05 | $190.60M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$53.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $138.20M 10-Q · filed 2021-08-05 | $416.10M derived: sum of 3 quarters · filed 2022-02-28 | $396.60M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $191.30M 10-Q · filed 2021-05-10 | $469.20M derived: sum of 2 quarters · filed 2022-02-28 | $449.70M derived: sum of 3 quarters · filed 2022-02-28 | $500.10M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $277.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $258.40M derived: sum of 2 quarters · filed 2022-02-28 | $308.80M derived: sum of 3 quarters · filed 2022-02-28 | $300.00M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$19.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $30.90M derived: sum of 2 quarters · filed 2020-11-06 | $22.10M 10-Q · filed 2020-11-06 | $98.70M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $50.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $41.60M 10-Q · filed 2020-08-07 | $118.20M derived: sum of 3 quarters · filed 2021-03-01 | $132.80M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$8.80M 10-Q · filed 2020-05-11 | $67.80M derived: sum of 2 quarters · filed 2021-03-01 | $82.40M derived: sum of 3 quarters · filed 2021-03-01 | $77.60M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $76.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $91.20M derived: sum of 2 quarters · filed 2021-03-01 | $86.40M derived: sum of 3 quarters · filed 2021-03-01 | -$112.40M 10-K · filed 2021-03-01 |
| 2018-09-30 | $14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $9.80M derived: sum of 2 quarters · filed 2019-11-04 | -$189.00M 10-Q · filed 2019-11-04 | -$278.50M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-06-30 | -$4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$203.60M 10-Q · filed 2019-08-09 | -$293.10M derived: sum of 3 quarters · filed 2020-03-27 | -$332.00M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-03-31 | -$198.80M 10-Q · filed 2019-05-08 | -$288.30M derived: sum of 2 quarters · filed 2020-03-27 | -$327.20M derived: sum of 3 quarters · filed 2020-03-27 | -$325.50M derived: sum of 4 quarters · filed 2020-03-27 |
| 2017-12-31 | -$89.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$128.40M derived: sum of 2 quarters · filed 2020-03-27 | -$126.70M derived: sum of 3 quarters · filed 2020-03-27 | -$159.00M 10-K · filed 2020-03-27 |
| 2017-09-30 | -$38.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$37.20M derived: sum of 2 quarters · filed 2018-11-09 | -$69.50M 10-Q · filed 2018-11-09 | -$43.40M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$30.60M 10-Q · filed 2018-08-09 | -$4.50M derived: sum of 3 quarters · filed 2019-03-01 | -$15.00M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$32.30M 10-Q · filed 2018-05-10 | -$6.20M derived: sum of 2 quarters · filed 2019-03-01 | -$16.70M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | $26.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $15.60M derived: sum of 2 quarters · filed 2019-03-01 | -$27.90M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$10.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$54.00M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$43.50M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | -$169.40M 10-K · filed 2018-03-16 | |||
| 2011-06-30 | -$9.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$14.00M 10-Q · filed 2011-08-09 | ||
| 2011-03-31 | -$4.10M 10-Q · filed 2011-05-09 | |||
| 2010-06-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | -$8.90M 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | -$4.30M 10-Q · filed 2011-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |